Related Experiment Video
Updated: May 26, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Pediatric vasculitis
1Department of Pediatrics, Hacettepe University Children's Hospital, Sıhhiye, Ankara, 06100, Turkey. ezgidenizbatu@yahoo.com
Insights
Childhood vasculitis, rare except for Henoch-Schönlein purpura and Kawasaki disease, involves complex etiopathogenesis. This review summarizes recent classification, pathophysiology, and treatment for these rare inflammatory conditions.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Vascular Medicine
Background:
- Primary systemic vasculitides in children are rare, with Henoch-Schönlein purpura and Kawasaki disease being notable exceptions.
- The exact causes (etiopathogenesis) of most childhood vasculitides remain unclear, though infectious triggers in susceptible individuals are suspected.
- Clinical presentations vary based on affected organs and vessel involvement, alongside constitutional symptoms.
Purpose of the Study:
- To review recent advancements in the classification criteria for childhood vasculitides.
- To summarize current understanding of the pathophysiologic pathways involved.
- To outline adapted treatment protocols for pediatric vasculitis.
Main Methods:
- Literature review focusing on recent studies and guidelines.
- Synthesis of data on classification, pathogenesis, and treatment of childhood vasculitides.
- Adaptation of adult treatment data for pediatric cases.
Main Results:
- Recent classification criteria have been validated for pediatric vasculitides.
- Environmental factors, particularly infections, are implicated in triggering inflammatory responses.
- Treatment strategies often rely on adult study data due to the rarity of these conditions in children.
Conclusions:
- Understanding and classifying childhood vasculitides have improved with recent criteria validation.
- Further research into etiopathogenesis is needed to elucidate triggers and mechanisms.
- Treatment protocols require careful adaptation from adult studies for effective pediatric management.
Abstract:
The primary systemic vasculitides in childhood are quite rare except for Henoch-Schönlein purpura and Kawasaki disease. These are usually self-limited diseases. The etiopathogenesis for most of them is not clearly understood. However, it is usually thought that environmental triggers (mostly infectious) evoke an aggravated inflammatory response in susceptible individuals. The classification criteria for most of them were recently validated for children. Clinical manifestations are determined by the organs affected, reflecting the involved vessels on a background of constitutional symptoms. For treatment, the main data are adapted from adult studies, especially for rarer vasculitides in childhood. In this review, the recent classification criteria, current pathophysiologic pathways, and treatment protocols are summarized.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

